Terns Pharmaceuticals, Inc. (TERN) Insider Trading

Over the last 3 months, TERN insiders made 0 open-market buys and 3 sales, a net sale of -$731K (SEC Form 4). Over the last 6 months, 197 institutions increased and 95 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$730.8K
Insider trades by month Buys Sells
Oct
Nov
Jan
Feb
Mar
Apr
Context3-month price +33.8%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Apr 2, 2026Kuriakose Emilofficer: Chief Medical OfficerSell942$52.75
Mar 17, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell11,813$46.57
Mar 17, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell2,770$47.30
Mar 17, 2026Burroughs Amy L.director, officer: Chief Executive OfficerOption14,583$4.64
Feb 18, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell2,341$38.07
Feb 18, 2026Burroughs Amy L.director, officer: Chief Executive OfficerOption14,583$4.64
Feb 18, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell4,083$39.80
Feb 18, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell8,159$39.22
Feb 2, 2026Turner Heather DdirectorGrant1,697$34.60
Feb 2, 2026Tripuraneni RadhikadirectorGrant1,697$34.60
Feb 2, 2026Azelby RobertdirectorGrant1,697$34.60
Feb 2, 2026Quigley Jill M.directorGrant1,697$34.60
Feb 2, 2026KINDLER JEFFREY BdirectorGrant1,697$34.60
Feb 2, 2026FELLOWS DAVID AdirectorGrant2,828$34.60
Jan 16, 2026Burroughs Amy L.director, officer: Chief Executive OfficerOption27,083$4.64
Jan 16, 2026Burroughs Amy L.director, officer: Chief Executive OfficerOption14,583$4.64
Jan 16, 2026Burroughs Amy L.director, officer: Chief Executive OfficerGrant300,000$37.18
Jan 16, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell61,228$37.02
Jan 16, 2026Burroughs Amy L.director, officer: Chief Executive OfficerGrant150,000—
Jan 16, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell7,521$37.53
Jan 16, 2026Gengos Andrewofficer: Chief Financial OfficerGrant68,750—
Jan 16, 2026Gengos Andrewofficer: Chief Financial OfficerGrant137,500$37.18
Jan 16, 2026Kuriakose Emilofficer: Chief Medical OfficerGrant56,250—
Jan 16, 2026Kuriakose Emilofficer: Chief Medical OfficerGrant112,500$37.18
Jan 6, 2026Kuriakose Emilofficer: Chief Medical OfficerSell955$38.36
Jan 6, 2026Burroughs Amy L.director, officer: Chief Executive OfficerOption21,551$4.64
Jan 6, 2026Burroughs Amy L.director, officer: Chief Executive OfficerOption150,000—
Jan 6, 2026Burroughs Amy L.director, officer: Chief Executive OfficerSell71,339$38.10
Jan 6, 2026Kuriakose Emilofficer: Chief Medical OfficerSell200$39.60
Nov 5, 2025Quigley Jill M.directorOption24,520$9.24

Source: TERN SEC Form 4 filings, latest Apr 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their TERN positions over the last 6 months (SEC Form 13F).

Increased
197
New positions
254
Reduced
95
Sold out
74
Largest moves
InstitutionActionSharesFiled
BLACKROCK, INC.Increased9.6MMay 13, 2026
BLACKROCK, INC.Increased8.2MFeb 12, 2026
MORGAN STANLEYIncreased7.9MFeb 13, 2026
MORGAN STANLEYReduced6.4MMay 15, 2026
AVORO CAPITAL ADVISORS LLCIncreased5.7MMay 15, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Increased5.5MFeb 17, 2026
VANGUARD GROUP INCIncreased5.5MJan 29, 2026
VIVO CAPITAL, LLCReduced5.3MFeb 13, 2026
VESTAL POINT CAPITAL, LPNew Position4.5MFeb 17, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4.4MMay 15, 2026
AVORO CAPITAL ADVISORS LLCNew Position4.3MMar 16, 2026
HOLOCENE ADVISORS, LPIncreased4.1MMay 15, 2026
JANUS HENDERSON GROUP PLCNew Position3.4MFeb 17, 2026
CITADEL ADVISORS LLCIncreased3.2MMay 15, 2026
CITADEL ADVISORS LLCIncreased3.2MFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to TERN overview (price, financials, earnings)